Tenet Healthcare (NYSE:THC) Releases FY 2025 Earnings Guidance

Tenet Healthcare (NYSE:THC) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 11.990-13.120 for the period, compared to the consensus estimate of 12.200. The company issued revenue guidance of $20.6 billion-$21.0 billion, compared to the consensus revenue estimate of $20.9 billion.

Tenet Healthcare Stock Performance

Tenet Healthcare stock opened at $123.82 on Tuesday. Tenet Healthcare has a fifty-two week low of $96.14 and a fifty-two week high of $171.20. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. The stock has a fifty day moving average of $126.27 and a two-hundred day moving average of $136.57. The company has a market capitalization of $11.69 billion, a price-to-earnings ratio of 3.84, a PEG ratio of 1.02 and a beta of 1.77.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. On average, analysts anticipate that Tenet Healthcare will post 12.24 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on THC. Guggenheim started coverage on shares of Tenet Healthcare in a report on Wednesday, April 9th. They issued a “buy” rating and a $165.00 target price on the stock. Truist Financial dropped their target price on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com raised Tenet Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, March 13th. TD Cowen started coverage on Tenet Healthcare in a report on Wednesday, February 26th. They set a “buy” rating and a $175.00 price target for the company. Finally, Baird R W downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $165.44.

Insider Buying and Selling at Tenet Healthcare

In related news, Director J Robert Kerrey sold 9,525 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the transaction, the director now owns 27,378 shares in the company, valued at $3,434,022.54. The trade was a 25.81 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.